跳至主要内容
临床试验/PACTR2010020001862624
PACTR2010020001862624尚未招募未知

Comparison of the safety, efficacy and tolerability of artemether¬-lumefantrine and artesunate amodiaquine in Nigerian pregnant women with acute uncomplicated falciparum malaria

Marcel Ukah0 个研究点目标入组 0 人开始时间: 2010年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 55 Year(s)(—)
性别
Female

入选标准

  • a)Microscopically-confirmed P. falciparum malaria with parasitaemia of atleast one plus(1-10 parasites /100 thick film field).
  • b)Fever (T of 37.50C) or a history of fever,headaches,body pains within 24 hours of presentation
  • c)Ability to give informed consent
  • d)Willingness/ability to comply with follow up visits.

排除标准

  • a)Severe malaria or danger signs of severe malaria (e.g. loss of consciousness, convulsions, anuria)
  • b)Women in the first 13 weeks of pregnancy i.e. 1st trimester
  • c)Use of any anti-malarial drug other than sulphadoxine pyrimethamine less than 7 days before presentation
  • d)Other chronic illness e.g. hypertension, sickle cell.
  • e)Other pregnancy related diseases e.g. eclampsia, antepartum hemorrhage
  • f)History of reaction to any of the study drugs
  • g)Patients not tolerating orally.

研究者

发起方
Marcel Ukah

相似试验